Shotty breast

Content


Shotty breast
Fibrocystic breast disease develops as a result
hormonal disruption in the body. It is a benign
formation able to move in some cases malignant
state. If the disease is detected in the early stages of its development, it is usually
successfully cured.

Fibrocystic breast disease - is a benign
breast disease, resulting in proliferative and regressive
variations in which the ratio of connective tissue and epithelium is disturbed.
Favorable background for its development is the availability of gynecological
diseases. It occurs in 30-70% of women of childbearing age.


Classification
pathological processes

There are knots and diffuse form of mastitis. disease in
diffuse form accompanied by the formation of glandular, fibrous or
cystic component. Often it develops in mixed form, with the presence of
components. The most common is diffuse fibrocystic
breast. The disease begins with the proliferation of connective tissue and
the formation of small cords and nodules. In the absence of appropriate treatment
the disease becomes an anchor shape with the formation of dense knots of different sizes
- From a pea to a walnut.

Kinds
mastitis

Accepted divide the disease into 2 types:

  • proliferation - with the active growth of
    epithelium and transition probability malignant neoplasms in the state;
  • non-proliferative - with a predominance of regressive
    processes.

In proliferative form of the disease distinguish 3 degree of
development:

  • 1 degree - there are pathological symptoms
    process, but changes the proliferative epithelium yet to occur;
  • 2 degree - are beginning to show signs of
    proliferation;
  • Grade 3 - epithelial cells exposed
    proliferation, transformed and become atypical.

Causes
fibrocystic breast

The main reason - hormonal disorders that trigger
tissue growth or vice versa, changes the regressive nature. Dairy
prostate sensitive to sex hormones produced by the ovaries, because
estrogen-progestin fluctuations are the main precipitating factor in the development
pathology.

Group
risk

The risk group includes women who have not given birth to 30 years,
overweight, high blood pressure and excess
blood sugar levels. The probability increases pathology in women
several times to terminate the pregnancy and give up breastfeeding after
delivery. The disease can also develop after severe stress or when
It is in a state of nervous tension for a long time.


symptoms
fibrocystic breast

Shotty breast
The most susceptible to changes verhnenaruzhnogo square gland
due to the nature of the structure and blood supply to the area. At an early stage
diseases in the second half of the cycle and during menstruation occurs
increase in breast size and pain therein. There
a feeling of heaviness in the chest, you may receive the status of anxiety and
irritability.

In the later stages of clinical observed following
picture:

  • persistent pain in the gland, not
    depending on the menstrual period, and worse when touched;
  • a significant increase in breast size and
    changing its contours;
  • constant feeling of heaviness and discomfort;
  • transition pains in the armpit;
  • nipple discharge serous matter, apparently
    reminiscent of colostrum.


Diagnostics
fibrocystic breast

After examination of the patient - a survey on the presence of symptoms and
palpation - appointed laboratory and instrumental investigations. at
laboratory studies carried out blood tests and determined content
It hormones. Instrumental methods include ultrasound
examination, computed tomography and mammography. The main methods
considered a mammogram (x-rays) and ultrasound, which
are safe and have no contra-indications and age restrictions.
The procedures are carried out on 6-12 day of the menstrual cycle in the absence of menstruation - any day. Perhaps the use of invasive techniques (puncture and biopsy). at
detecting areas restructured or nodules usually
breast biopsy tissue sample and cytological studies.
Discharge from the nipple is also sent to the cytological analysis.


Treatment
cystic disease of breast

The treatment is chosen individually, depending
on the form of mastitis, the state of the hormonal system and the availability of gynecological
diseases. The aim of therapeutic methods is to reduce the number of cysts
and areas of fibrous tissues, regulation of hormone levels in the blood and functions
the liver, kidneys and CNS. Measures are taken to eliminate and endocrine pathologies
inflammatory processes. In advanced stages, the transition of the disease in
nodular, possibly surgery.

Leave a reply